These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15920056)

  • 1. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.
    van Hecke MV; Dekker JM; Stehouwer CD; Polak BC; Fuller JH; Sjolie AK; Kofinis A; Rottiers R; Porta M; Chaturvedi N;
    Diabetes Care; 2005 Jun; 28(6):1383-9. PubMed ID: 15920056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
    Tielemans SM; Soedamah-Muthu SS; De Neve M; Toeller M; Chaturvedi N; Fuller JH; Stamatakis E
    Diabetologia; 2013 Jan; 56(1):82-91. PubMed ID: 23052062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark.
    Grauslund J; Green A; Sjølie AK
    Diabetologia; 2008 Apr; 51(4):583-8. PubMed ID: 18297258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
    Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus.
    Gimeno-Orna JA; Faure-Nogueras E; Castro-Alonso FJ; Boned-Juliani B
    Am J Cardiol; 2009 May; 103(10):1364-7. PubMed ID: 19427429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study.
    Schoenaker DA; Toeller M; Chaturvedi N; Fuller JH; Soedamah-Muthu SS;
    Diabetologia; 2012 Aug; 55(8):2132-41. PubMed ID: 22526612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic retinopathy and mortality in type 2 diabetic patients].
    Gimeno Orna JA; Castro Alonso FJ; Sánchez Vañó R; Latre Rebled B; Lou Arnal LM; Molinero Herguedas E
    Med Clin (Barc); 2006 May; 126(18):686-9. PubMed ID: 16759576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study.
    Garofolo M; Gualdani E; Giannarelli R; Aragona M; Campi F; Lucchesi D; Daniele G; Miccoli R; Francesconi P; Del Prato S; Penno G
    Cardiovasc Diabetol; 2019 Nov; 18(1):159. PubMed ID: 31733651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.
    Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A
    J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy predicts coronary heart disease events in NIDDM patients.
    Miettinen H; Haffner SM; Lehto S; Rönnemaa T; Pyörälà K; Laakso M
    Diabetes Care; 1996 Dec; 19(12):1445-8. PubMed ID: 8941482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.
    J Hypertens; 1993 Mar; 11(3):319-25. PubMed ID: 8387090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Witte DR; Jørgensen ME
    Diabetologia; 2019 Apr; 62(4):633-643. PubMed ID: 30649599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.
    Foussard N; Saulnier PJ; Potier L; Ragot S; Schneider F; Gand E; Monlun M; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Mohammedi K; Hadjadj S;
    Diabetes Care; 2020 Nov; 43(11):2751-2759. PubMed ID: 33055101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).
    Soedamah-Muthu SS; Chaturvedi N; Pickup JC; Fuller JH;
    Diabetologia; 2008 Mar; 51(3):493-501. PubMed ID: 18183363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.